Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Bone Marrow Transplantation (20)
Blood Cancer Journal (1)
Nature Communications (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (18)
Correspondence (3)
Amendments and Corrections (1)
Comments & Opinion (1)

Subject Check one or more subjects to show results from those subjects only.

Biotechnology
Cancer
Diseases
Health care
Immunology
Medical research
Risk factors
Stem cells

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–23 of 23 results

Advanced filters: Author: Raynier Devillier Clear advanced filters

Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC

Maxime Jullien
Eolia Brissot
Amandine Le Bourgeois
Research15 Sept 2025
Bone Marrow Transplantation

P: 1-9
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome

Samia Harbi
Louison Brac de la Perriere
Raynier Devillier
Research03 Nov 2023
Bone Marrow Transplantation

Volume: 59, P: 101-106
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study

Jules Higué
Corentin Orvain
Christian Récher
CorrespondenceOpen Access21 Aug 2025
Blood Cancer Journal

Volume: 15, P: 1-4
Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome

Luca Castagna
Thomas Pagliardini
Raynier Devillier
Research15 Nov 2020
Bone Marrow Transplantation

Volume: 56, P: 883-889
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients

Angela Granata
Sabine Fürst
Raynier Devillier
Research19 Mar 2019
Bone Marrow Transplantation

Volume: 54, P: 1730-1737
Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

Charlotte Nykolyszyn
Angela Granata
Raynier Devillier
Research18 Sept 2019
Bone Marrow Transplantation

Volume: 55, P: 349-355
Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years

Mathias Debals-Gonthier
Carole Siani
Anne-Gaëlle Le Corroller Soriano
Research09 Mar 2018
Bone Marrow Transplantation

Volume: 53, P: 1096-1104
Clinical outcome of FLAG-IDA chemotherapy sequential with Flu–Bu3 conditioning regimen in patients with refractory AML: a parallel study from Shanghai Institute of Hematology and Institut Paoli-Calmettes

Ling Wang
Raynier Devillier
Jiong Hu
ResearchOpen Access06 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 458-464
Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients

Thomas Pagliardini
Samia Harbi
Raynier Devillier
Research06 Nov 2018
Bone Marrow Transplantation

Volume: 54, P: 1067-1076
Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation

Raynier Devillier
Myriam Labopin
Mohamad Mohty
Research12 Jan 2018
Bone Marrow Transplantation

Volume: 53, P: 431-437
Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing

Host versus graft reaction is a major impediment to CAR-T cell immune therapy in allogeneic settings. Authors show here that CAR-T cells, engineered to be deficient in MHC I expression but to express the NK inhibitor HLA-E, are resistant to destruction by both T and NK cells of the host.

Sumin Jo
Shipra Das
Julien Valton
ResearchOpen Access30 Jun 2022
Nature Communications

Volume: 13, P: 1-16
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation

Post-transplantation relapse in acute myeloid leukemia patients without genomic loss of HLA is driven by transcriptional alterations in antigen presentation and T cell costimulation genes.

Cristina Toffalori
Laura Zito
Luca Vago
Research25 Mar 2019
Nature Medicine

Volume: 25, P: 603-611
Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

Rémy Duléry
Claire Goudet
Raynier Devillier
Research30 Dec 2022
Bone Marrow Transplantation

Volume: 58, P: 386-392
Transplantation for myelofibrosis patients in the ruxolitinib era: a registry study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire

Sara Villar
Sylvie Chevret
Marie Robin
Research21 Mar 2024
Bone Marrow Transplantation

Volume: 59, P: 965-973
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease

Sabine Fürst
Emmanuelle Bernit
Didier Blaise
Research14 Mar 2024
Bone Marrow Transplantation

Volume: 59, P: 918-927
Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC

Gaëlle Rey
Elisabeth Daguenet
Emmanuelle Tavernier
Research31 Aug 2023
Bone Marrow Transplantation

Volume: 58, P: 1331-1338
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation

François Dachy
Sabine Furst
Raynier Devillier
Comments & Opinion09 Aug 2023
Bone Marrow Transplantation

Volume: 58, P: 1179-1181
Correction: Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

Nicole Santoro
Jarl E. Mooyaart
Christian Chabannon
Amendments and Corrections14 Dec 2022
Bone Marrow Transplantation

Volume: 58, P: 119-120
Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

Nicole Santoro
Jarl E. Mooyaart
Christian Chabannon
Research10 Oct 2022
Bone Marrow Transplantation

Volume: 58, P: 54-60
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT

Raynier Devillier
Jacques-Emmanuel Galimard
Mohamad Mohty
Research25 Jun 2022
Bone Marrow Transplantation

Volume: 57, P: 1421-1427
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide

Jacopo Mariotti
Anna Maria Raiola
Luca Castagna
Research03 Sept 2022
Bone Marrow Transplantation

Volume: 57, P: 1758-1764
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

Jacopo Mariotti
Angela Granata
Luca Castagna
Correspondence24 Jan 2019
Bone Marrow Transplantation

Volume: 54, P: 1164-1167
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

Jacopo Mariotti
Stefania Bramanti
Luca Castagna
Correspondence21 Dec 2017
Bone Marrow Transplantation

Volume: 53, P: 366-370